Pharmacokinetics Study of XG005 Capsule

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 16, 2017

Primary Completion Date

January 18, 2018

Study Completion Date

March 19, 2018

Conditions

Pain

Interventions

DRUG

XG005

XG005 Capsule

DRUG

Combination of Naproxen and Pregabalin

Naproxen and Pregabalin are commercially available products with trade names of Aleve and Lyrica

DRUG

Placebos

Placebo Capsule

Trial Locations (1)

Linear Clinical Research Ltd, Nedlands

All Listed Sponsors

lead

Xgene Pharmaceutical Group

INDUSTRY

NCT04499209 - Pharmacokinetics Study of XG005 Capsule | Biotech Hunter | Biotech Hunter